A Study of LY3478045 in Healthy Participants

NCT04270370 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3478045
DRUG: Placebo
DRUG: Atorvastatin

Sponsor

Eli Lilly and Company